Every one of those 1 sits in a single category, medical-devices. Biofabrication is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Healthcare story that mention IIT Bombay, all published on July 5, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about IIT Bombay
Every one of those 1 sits in a single category, medical-devices. Biofabrication is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Healthcare story that mention IIT Bombay, all published on July 5, 2026. Each carries 5 original sources on average.
Stories tracked
1
Sources per story
5
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 4 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering IIT Bombay. Shared-story counts are live from our verified record — not editorial picks.
An affordable, lab-friendly placenta-on-chip from India reproduces hormone secretion, nutrient transfer, waste removal, and barrier function, while modeling gestational diabetes. Its simple design may replace animal models for drug safety screening in pregnancy.